| Title |
Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance
|
|---|---|
| Published in |
Journal of Clinical Oncology, March 2019
|
| DOI | 10.1200/jco.18.01512 |
| Pubmed ID | |
| Authors |
Toshiya Abe, Amanda L Blackford, Koji Tamura, Madeline Ford, Patrick McCormick, Miguel Chuidian, Jose Alejandro Almario, Michael Borges, Anne Marie Lennon, Eun Ji Shin, Alison P Klein, Ralph H Hruban, Marcia I Canto, Michael Goggins |
X Demographics
The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 27% |
| Brazil | 2 | 9% |
| Spain | 1 | 5% |
| United Kingdom | 1 | 5% |
| Unknown | 12 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 50% |
| Practitioners (doctors, other healthcare professionals) | 5 | 23% |
| Science communicators (journalists, bloggers, editors) | 3 | 14% |
| Scientists | 3 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 68 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 21% |
| Student > Ph. D. Student | 6 | 9% |
| Student > Bachelor | 4 | 6% |
| Other | 4 | 6% |
| Student > Master | 4 | 6% |
| Other | 11 | 16% |
| Unknown | 25 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 32% |
| Biochemistry, Genetics and Molecular Biology | 8 | 12% |
| Nursing and Health Professions | 3 | 4% |
| Immunology and Microbiology | 2 | 3% |
| Computer Science | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 29 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2019.
All research outputs
#1,979,719
of 25,775,807 outputs
Outputs from Journal of Clinical Oncology
#4,730
of 22,244 outputs
Outputs of similar age
#45,219
of 380,356 outputs
Outputs of similar age from Journal of Clinical Oncology
#99
of 253 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,244 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,356 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.